Read More

Reported Late Wednesday March 08, GIO World Health Announces Plans To Go Public Via Business Combination With Apeiron Capital Investment; Will Be Listed On Either The NYSE Or NASDAQ, And Will Be Renamed “Gio World Health Holdings, Inc.”

GIO World Health Ltd ("GIO World Health") has entered into a business combination agreement with Apeiron Capital Investment Corp (APNC). The post-closing combined public company, which will be named GIO

APNC

Read More

Reported Late Wednesday March 08, Canadian Natural Resources Limited Announces Normal Course Issuer Bid Through The TSX; Commencing March 13, 2023 And Ending March 12, 2024, Purchase For Cancellation Up To 92,296,006 Shares, Being 10% Of The Public Flo…

 Canadian Natural Resources Limited (TSX:CNQ) (NYSE:CNQ) ("Canadian Natural") announced today that the Toronto Stock Exchange has accepted notice filed by Canadian Natural of its intention to make a Normal

CNQ

Read More

Reported Late Wednesday March 08, Neoleukin Therapeutics Provides Strategic Update And Announces Restructuring And Leadership Transition; Chief Executive Officer Jonathan Drachman, M.D., Will Be Stepping Down After A Short Transition

Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced that it has

NLTX

Read More

Reported Late Wednesday March 08, LSI Industries Introduces Strategic Plan Update, 5-Year Financial Targets; “Fast Forward” Strategy To Deliver $800M In Net Sales And $100M Adjusted EBITDA By FY28; Sees FY23 Revenue $490M-$500M Vs $496.88M Est

"Fast Forward" Strategy to Deliver $800 million in Net Sales and $100 million Adjusted EBITDA by FY28 LSI Industries Inc. (NASDAQ:LYTS, ", LSI", or the ", Company", )))) a

LYTS